Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Titel:
Health-related quality of life and neurocognitive functioning with lomustine–temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Auteur:
Weller, Johannes Tzaridis, Theophilos Mack, Frederic Steinbach, Joachim Peter Schlegel, Uwe Hau, Peter Krex, Dietmar Grauer, Oliver Goldbrunner, Roland Bähr, Oliver Uhl, Martin Seidel, Clemens Tabatabai, Ghazaleh Brehmer, Stefanie Bullinger, Lars Galldiks, Norbert Schaub, Christina Kebir, Sied Stummer, Walter Simon, Matthias Fimmers, Rolf Coch, Christoph Glas, Martin Herrlinger, Ulrich Schäfer, Niklas